SK91498A3 - Nisin in combination with glycerol monolaurate active against helicobacter - Google Patents

Nisin in combination with glycerol monolaurate active against helicobacter Download PDF

Info

Publication number
SK91498A3
SK91498A3 SK914-98A SK91498A SK91498A3 SK 91498 A3 SK91498 A3 SK 91498A3 SK 91498 A SK91498 A SK 91498A SK 91498 A3 SK91498 A3 SK 91498A3
Authority
SK
Slovakia
Prior art keywords
administered
agent
administration
agents
treatment
Prior art date
Application number
SK914-98A
Other languages
English (en)
Slovak (sk)
Inventor
Peter Blackburn
Beth P Goldstein
Debra J Cook
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Publication of SK91498A3 publication Critical patent/SK91498A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK914-98A 1996-01-05 1997-01-02 Nisin in combination with glycerol monolaurate active against helicobacter SK91498A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US987296P 1996-01-05 1996-01-05
PCT/US1997/000186 WO1997025055A1 (en) 1996-01-05 1997-01-02 Nisin in combination with glycerol monolaurate active against helicobacter

Publications (1)

Publication Number Publication Date
SK91498A3 true SK91498A3 (en) 1999-05-07

Family

ID=21740219

Family Applications (1)

Application Number Title Priority Date Filing Date
SK914-98A SK91498A3 (en) 1996-01-05 1997-01-02 Nisin in combination with glycerol monolaurate active against helicobacter

Country Status (17)

Country Link
US (1) US5804549A (cs)
EP (1) EP0871469A1 (cs)
JP (1) JP2001517199A (cs)
KR (1) KR19990077069A (cs)
CN (1) CN1117585C (cs)
AU (1) AU720568B2 (cs)
BR (1) BR9706963A (cs)
CA (1) CA2241464C (cs)
CZ (1) CZ208598A3 (cs)
HU (1) HUP9900940A2 (cs)
IL (1) IL124972A0 (cs)
NO (1) NO983097L (cs)
NZ (1) NZ327006A (cs)
PL (1) PL327507A1 (cs)
SK (1) SK91498A3 (cs)
WO (1) WO1997025055A1 (cs)
ZA (1) ZA9610945B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) * 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6248551B1 (en) * 1997-03-28 2001-06-19 Institut Pasteur Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides
US5942409A (en) * 1998-07-31 1999-08-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for identification of substances modulating ureI dependent mechanisms of Helicobacter pylori metabolism
KR100460173B1 (ko) * 1998-12-11 2004-12-04 겐 코오포레이션 헬리코박터 파일로리 정착 억제제
KR100518263B1 (ko) * 2002-11-21 2005-10-04 학교법인 한마학원 락토코쿠스 락티스 ｎｋ24 (ｋｆｃｃ 11315) 생균을유효성분으로 함유하는 것을 특징으로 하는 위장병 예방및 치료용 조성물
AP2005003346A0 (en) * 2002-12-10 2005-06-30 Biosynexus Inc Topical anti-infective formulations
CN100534334C (zh) * 2003-09-09 2009-09-02 3M创新有限公司 浓缩的抗菌组合物和方法
US20050053593A1 (en) * 2003-09-09 2005-03-10 3M Innovative Properties Company Antimicrobial compositions and methods
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
CA2578404A1 (en) * 2004-08-23 2006-03-02 Auckland Uniservices Limited Gastric therapies and compositions therefor
CA2599667C (en) 2005-03-10 2014-12-16 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxy carboxylic acids
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
CA2599653A1 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
EP1858506A2 (en) 2005-03-10 2007-11-28 3M Innovative Properties Company Methods of treating ear infections
WO2006099232A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Antimicrobial pet wipes
MY140578A (en) 2005-12-07 2009-12-31 Malaysian Agricultural Res And Dev Inst Mardi Modified coconut oils with broad antimicrobial spectrum
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
CN102100687B (zh) * 2009-12-17 2012-10-03 美利泰格诊断试剂(嘉兴)有限公司 聚赖氨酸在制备杀灭口腔螺旋杆菌药物的应用
KR100980254B1 (ko) * 2010-02-02 2010-09-06 주식회사 페모지아 위염, 궤양의 원인이 되는 헬리코박터 파일로리균 살균을 위한 폴리라이신과 글리세롤 모노라우레이트를 함유하는 조성물
CN103636633B (zh) * 2013-11-26 2015-12-02 广西安泰化工有限责任公司 淀粉作为农药填料的应用
US20160095876A1 (en) 2014-10-01 2016-04-07 Rochal Industries, Llp Composition and kits for inhibition of pathogenic microbial infection and methods of using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485029A (en) * 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US5217950A (en) * 1988-06-22 1993-06-08 Applied Microbiology, Inc. Nisin compositions for use as enhanced, broad range bactericides
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5135910A (en) * 1988-06-22 1992-08-04 The Public Health Research Institute Of The City Of New York Nisin compositions for use as enhanced, broad range bactericides
HU204980B (en) * 1988-06-22 1992-03-30 New York Health Res Inst Agents containing bactericidal of lanthionine content and method for producing same
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US5328846A (en) * 1989-08-03 1994-07-12 The Penn State Research Foundation Method for removing exogenous deposits from hydrophilic contact lenses
GB9108080D0 (en) * 1991-04-15 1991-06-05 Smithkline Beecham Plc Pharmaceutical composition
ATE141511T1 (de) * 1991-04-15 1996-09-15 Applied Microbiology Inc Verwendung eines bakteriozin antibiotischen agenten zur herstellung eines arzneimittels zur behandlung von magenverstimmungen, die durch helicobacter pylori verursacht werden.
JPH08504401A (ja) * 1992-10-29 1996-05-14 デネッケ，ライナー 消化管疾患の治療および特に予防用製剤

Also Published As

Publication number Publication date
IL124972A0 (en) 1999-01-26
NO983097D0 (no) 1998-07-03
EP0871469A1 (en) 1998-10-21
CZ208598A3 (cs) 1998-12-16
CN1207045A (zh) 1999-02-03
AU1572197A (en) 1997-08-01
CN1117585C (zh) 2003-08-13
NZ327006A (en) 2000-10-27
CA2241464C (en) 2001-10-16
US5804549A (en) 1998-09-08
AU720568B2 (en) 2000-06-08
KR19990077069A (ko) 1999-10-25
BR9706963A (pt) 1999-05-04
ZA9610945B (en) 1997-06-30
NO983097L (no) 1998-09-04
JP2001517199A (ja) 2001-10-02
PL327507A1 (en) 1998-12-21
WO1997025055A1 (en) 1997-07-17
HUP9900940A2 (hu) 1999-07-28
CA2241464A1 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
SK91498A3 (en) Nisin in combination with glycerol monolaurate active against helicobacter
US20090156484A1 (en) Use of Transferrins for Treating Destructive Inflammation of Mucous Membrane
EP0671943B1 (en) Use of enzymes, especially bromelain, in the treatment of non-infectious diarrhoea
US20200254014A1 (en) Antimicrobial compositions and methods for their production
US20240189384A1 (en) Compositions Comprising Antimicrobial Peptides
US20180042999A1 (en) Multimodal Antimicrobial Therapy
Francioli et al. Successful prophylaxis of experimental streptococcal endocarditis with single doses of sublethal concentrations of penicillin
JP3224131B2 (ja) 菌、卵白及びにんにくの２種以上を含有する免疫賦活・感染防御剤
TW491700B (en) Novel compositions with activity against helicobacter
Henry et al. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low-or high-dose streptomycin
US20220008521A1 (en) Pharmaceutical composition comprising ancrod for the treatment or prophylaxis of endocarditis
CN1256982C (zh) 达福普汀/奎奴普丁与头孢匹罗的组合形式
WO2006095433A1 (ja) ウシの消化器疾患治療剤
WO2015100447A2 (en) Ultra-low dose lysostaphin for treating mrsa
WO1996022105A1 (en) Pharmaceutical formulations comprising a salt of clavulanic acid, vancomycin and one or more beta-lactam antibiotics
NZ713792B2 (en) Antimicrobial compositions and methods for their production
WO2006123969A2 (en) Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthrasis, anthrax preventing and treating method